Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X-22 for Smoking Cessation
NCT01400815Phase 2Completed
- Sponsor
- 22nd Century Group
- Start
- Jul 2011
- Primary completion
- Dec 2012
- Modality
- Botanical product
- Countries
- 1
01
Overview
A Phase 2 trial of X-22 in Tobacco Use Disorder (TUD), sponsored by 22nd Century Group. Started Jul 2011; status: completed.
02
Drugs
X-22
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01400815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400815.